Inventor · disambiguated record
Miriam Royo Exposito
Also filed as: ROYO EXPOSITO MIRIAM · ROYO EXPÓSITO MIRIAM
3 granted patents·6 pending applications·3 citations·filing 2005–2022
54Inventor score
Files withLANDSTEINER GENMED S L3GENMEDICA THERAPEUTICS SL2AYMAMI BOFARULL JUAN1CONSEJO SUPERIOR DE INVESTIG CIENTÍFICAS (CSIC)1CONSEJO SUPERIOR INVESTIGACION1
Top patents by PatentIndex Score
9 records- 0169US9744247B2Functionalized liposomes useful for the delivery of bioactive compoundsCONSEJO SUPERIOR DE INVESTIG CIENTÍFICAS (CSIC)·Filed 2013·Granted Aug 29, 2017·2 cites·19 claims
- 0255US10294269B2Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulationLANDSTEINER GENMED S L·Filed 2015·Granted May 21, 2019·1 cites·24 claims
- 0346US2024115502A1Liposomes and its use for enzyme deliveryCONSEJO SUPERIOR INVESTIGACION·Filed 2022·Application pending·0 cites
- 0443US2019270770A1Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulationLANDSTEINER GENMED S L·Filed 2019·Application pending·0 cites
- 0537US2010129800A1Polymers and their use as fluorescent labelsAYMAMI BOFARULL JUAN·Filed 2008·Application pending·0 cites
- 0637US2008070987A1Meta-xylylenediamine vanadate saltsYRAOLA FONT FRANCESC·Filed 2007·Application pending·0 cites
- 0736US11242312B2Dipeptidyl ketoamide meta-methoxyphenyl derivatives and uses thereofLANDSTEINER GENMED S L·Filed 2019·Granted Feb 8, 2022·0 cites·20 claims
- 0833US2008227809A1Arylalkylamine Vanadium (V) Salts for the Treatment and/or Prevention of Diabetes MellitusGENMEDICA THERAPEUTICS SL·Filed 2005·Application pending·0 cites
- 0929US2008269282A1Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses ThereofGENMEDICA THERAPEUTICS SL·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Miriam Royo Exposito files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →